- Companies
- myLaurel
myLaurel Valuation, Funding & Investors
myLaurel is valued at $350M as of September 2020.
Last myLaurel valuation
$350M
Series C · Sep 2020
Last myLaurel funding round
$12M
Series A · Jun 2025
Cumulative funding myLaurel raised
$119M
across 5 funding rounds
Key investors in myLaurel
City Light Capital
GV
Deerfield
Justin Mateen
Frist Cressey Ventures
Town Hall Ventures
About myLaurel
myLaurel is a U.S.-based healthcare provider offering in-home acute care, telemedicine, and post-discharge follow-up to prevent hospital readmissions. Operating as Ready Responders, it delivers 16-hour daily whole-person care through in-network partnerships with major insurers. Backed by investors including Google Ventures and Founders Fund, myLaurel serves patients in select markets with programs reducing utilization risks. Services include nurse visits, virtual consultations, and monitoring for chronic conditions, emphasizing home-based alternatives to traditional hospital stays.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Valuation
$350M (Sep 2020)
Sectors
myLaurel Valuation
myLaurel is currently valued at $350M, based on its Series C in September 2020.
The $54M round included Frist Cressey Ventures, Town Hall Ventures, GV, City Light Capital and Deerfield.
myLaurel valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Sep 2020 | Series C | $350M |
myLaurel Funding History
myLaurel has raised a total of $119M across 5 funding rounds.
myLaurel's first fundraising round was a $700K seed round in July 2017. The most recent completed round was a $12M Series A in June 2025.
myLaurel funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jun 2025 | Series A | Deerfield (lead); GV (lead); Pinta Partners; Emerson Collective; Ochsner Lafayette General | $12M | - | myLaurel is a home-based acute and transitional care provider that delivers hospital-level medical treatment in patient homes through a combination of technology infrastructure and in-market clinical teams. The company's Acute Care at Home model enables hospitals to safely treat complex patients outside traditional inpatient settings, reducing hospital bed strain and generating measurable clinical and financial returns for health system partners. In June 2025, myLaurel closed $12 million in new funding from existing investors, led by Deerfield Management and GV (Google Ventures), with participation from Emerson Collective, Pinta Partners, Ochsner Health, and management. The round was structured as a convertible note, effectively positioning it between seed and Series A funding stages. This capital raise brought myLaurel's cumulative funding to approximately $119.4 million. The company demonstrated strong operational momentum heading into the round, with a record-breaking 2024 and a 4x year-over-year increase in new patient volume and revenue in Q1 2025. myLaurel reported key clinical outcomes including a 49% reduction in hospital readmissions, patient satisfaction scores above 90 NPS, and a six-to-one return on investment for hospital partners. MyLaurel operates primarily through partnerships with major health systems including Ochsner Health, LCMC Health, and Maimonides Medical Center in New York and Louisiana. The company's leadership team includes CEO Juan Vallarino, who brings experience scaling value-based care models, and President and Chief Medical Officer Dr. Marcy Carty. The capital was earmarked to expand the geographic footprint into additional markets, deepen existing health system partnerships, and build clinical infrastructure to support nationwide growth. |
| Sep 2020 | Series C | Frist Cressey Ventures; Town Hall Ventures; GV; City Light Capital; Deerfield | $54M | $350M | myLaurel is a tech-enabled healthcare company delivering home-based acute and transitional care to frail, elderly, and medically complex patients. The company provides hospital-level care in patient homes, combining clinical response teams with AI-enabled technology infrastructure that coordinates logistics, documentation, and physician oversight. In September 2020, myLaurel completed a Series C funding round raising $54 million led by multiple prominent healthcare and technology investors including City Light Capital, Deerfield Management, Frist Cressey Ventures, Google Ventures (GV), and Town Hall Ventures. The company's care model demonstrates strong clinical and financial outcomes, including a 49% reduction in readmissions and a six-to-one return on investment for hospital partners. By 2024-2025, myLaurel had expanded operations to major U.S. markets including New York City and New Orleans through partnerships with health systems such as Ochsner Health, LCMC Health, and Maimonides Medical Center, achieving a 4x year-over-year increase in new patient volume and revenue in 2024. |
| Mar 2020 | Series B | Deerfield (lead); GV (lead); Frist Cressey Ventures; Town Hall Ventures; City Light Capital | $48M | - | myLaurel is a healthcare company providing tech-enabled home-based acute and transitional care, partnering with health systems to deliver hospital-level treatment in patients' homes, reducing readmissions and freeing up hospital capacity. The company operates in markets like New York and Louisiana through partnerships with Ochsner Health, LCMC Health, and Maimonides Medical Center, reporting outcomes such as 49% reduction in readmissions, six-to-one ROI for partners, and patient NPS above 90. Later developments include a $12M round in June 2025 led by Deerfield and GV for expansion, following record 2024 growth with 4x YoY increase in patient volume and revenue, and investments like from SteelSky Ventures to scale in-home acute care platforms. |
| Dec 2018 | Series A | City Light Capital (lead); Acumen; Justin Mateen; Acumen America | $5M | - | - |
| Jul 2017 | Seed | MaC Venture Capital; Justin Mateen; Summit Action; City Light Capital | $700K | - | - |
Who has invested in myLaurel?
13 investors have backed myLaurel across its funding rounds, including City Light Capital, GV, Deerfield, Justin Mateen, Frist Cressey Ventures and Town Hall Ventures.
Lead investors include Deerfield, GV and City Light Capital.
myLaurel Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Jul 2017 | ||
| 3 | Lead | Mar 2020 | ||
| 3 | Lead | Mar 2020 | ||
| 2 | Participant | Mar 2020 | ||
| 2 | Participant | Mar 2020 | ||
| 2 | Participant | Jul 2017 | ||
| 1 | Participant | Jun 2025 | ||
| 1 | Participant | Dec 2018 | ||
| 1 | Participant | Jun 2025 | ||
| 1 | Participant | Jul 2017 | ||
| 1 | Participant | Jul 2017 | ||
This data is available for Pro users. Sign up to see all 13 myLaurel investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialmyLaurel Competitors
myLaurel competitors include listed companies like Carriage Services and Angi, and private ones like Snabbit, Aiper, HomeLane and Portea Medical.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $11M | - | $350M | - | ||
| Private | - | - | $370M | - | ||
| Private | $96M | - | $321M | 3.3x | ||
| Private | $17M | - | $267M | 15.7x | ||
| Publicly listed | $417M | $124M | $491M | 2.4x | ||
| Publicly listed | $1B | $114M | $215M | 0.4x |
myLaurel Public Comps
myLaurel is still privately-owned, but its public comps include Angi, Carriage Services, HomeMaid, Grupa Klepsydra, K2 LT, Service Corporation International and Rollins.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1B | $114M | 0.4x | 0.4x | 3.7x | 3.6x | |||
| $417M | $124M | 2.5x | 2.4x | 8.3x | 7.7x | |||
| $61M | $7M | 1.1x | 0.9x | 8.9x | 8.6x | |||
| $15M | $2M | 3.4x | - | 22.7x | - | |||
| - | - | - | - | - | - | |||
This data is available for Pro users. Sign up to see all myLaurel competitors and their valuation data. Start Free Trial | ||||||||
Common questions about myLaurel
| When was myLaurel founded? | myLaurel was founded in 2016. |
| Where is myLaurel headquartered? | myLaurel is headquartered in New York City, NY, United States. |
| Is myLaurel publicly listed? | No, myLaurel is a private, VC-backed company. |
| What is myLaurel's valuation? | myLaurel was last valued at $350M in its Series C in September 2020. |
| How much funding has myLaurel raised? | myLaurel has raised $119M across 5 funding rounds. |
| What was myLaurel's last funding round? | myLaurel's last funding round was a $12M Series A in June 2025, led by Deerfield and GV. |
| Who are myLaurel's investors? | myLaurel's investors include City Light Capital, GV, Deerfield, Frist Cressey Ventures, Town Hall Ventures, Justin Mateen, Pinta Partners, Acumen, Emerson Collective, MaC Venture Capital and 3 others. |
| Which companies are comparable to myLaurel? | Companies comparable to myLaurel include Snabbit, Aiper, HomeLane, Portea Medical, Carriage Services and Angi. |
See companies similar to myLaurel
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




